Last reviewed · How we verify
NCT04360460
Role of Functional Translation After Immersive Virtual Reality Exposure in Persons With Stroke
NA trial testing Immersive virtual reality + related functional translation into real-life in Hemiparesis as Late Effect of Cerebrovascular Disease in 10 participants. Completed in 18 August 2022.
18 August 2022
Quick facts
| Lead sponsor | Loma Linda University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 3 December 2020 |
| Primary completion | 18 August 2022 |
| Estimated completion | 18 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Immersive virtual reality + related functional translation into real-life
- Immersive virtual reality + non-related translation into real-life
Conditions studied
- Hemiparesis as Late Effect of Cerebrovascular Disease — all drugs for Hemiparesis as Late Effect of Cerebrovascular Disease →
Sponsor
Loma Linda University
Who can join
Adults 18 to 90, any sex, with Hemiparesis as Late Effect of Cerebrovascular Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-blinded randomized control trial aiming to explore the use of immersive virtual reality (VR) training in conjunction with real-life tasks therapy in 75 first time stroke patients with upper limb weakness.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04360460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Loma Linda University trials
Trials by the same sponsor.
- NCT07213843 — Combined Circulatory and Dietary Interventions for Neuropathy · NA · not yet recruiting
- NCT07130812 — Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain. · NA · recruiting
- NCT06673342 — Effectiveness of a Nutritional Counseling Tool in Reducing the Amount and Frequency of Sugar Intake · NA · completed
- NCT06445842 — Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women · NA · recruiting
- NCT07396831 — Necessity of Post-operative Eye Drops · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04360460 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Loma Linda University
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing